Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. Ambrisentan was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated an orphan drug, for the treatment of pulmonary hypertension. Reference standards of Ambrisentan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Diphenylacetaldehyde (BSC) [catalogue_number] => PA BSC 04628601 [category_ids] => ,169, [chemical_name] => [weight] => 196.25 [form] => C14H12O [cas] => 947-91-1 [pslug] => 947-91-1-diphenylacetaldehyde-bsc-pabsc04628601 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 04628601
CAS :
Molecular Formula : C14H12O
Molecular Weight : 196.25
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
